What are two of the trade names of the medication designed, synthesized, and patented by Indian-born American organic chemist and pharmacologist Nariman Bomanshaw Mehta?
Nariman Mehta Nariman Bomanshaw Mehta (April 8, 1920 – August 22, 2014) was an Indian-born American organic chemist and pharmacologist who designed, synthesized, and patented the organic compound Bupropion, marketed under the name Wellbutrin as an antidepressant and smoking cessation aid.
Solriamfetol Solriamfetol (developmental code names JZP-110, ADX-N05, others) is a norepinephrine–dopamine reuptake inhibitor (NDRI) which is under development by Jazz Pharmaceuticals for the treatment of narcolepsy, sleep apnea, hypersomnia, and renal failure. It is a low-potency NDRI, with respective IC values for the dopamine and norepinephrine transporters of 2.9 and 4.4 μM, and shows a low abuse liability. As of July 2017, it is in phase III clinical trials for narcolepsy and sleep apnea, phase II clinical trials for hypersomnia, and phase I clinical trials for renal failure.